Cargando…

Acute 5-HT(2C) Receptor Antagonist SB-242084 Treatment Affects EEG Gamma Band Activity Similarly to Chronic Escitalopram

Serotonin 2C receptors (5-HT(2C)Rs) are implicated in the pathomechanism and treatment of anxiety and depression. Recently, as a new biomarker of depression, alterations in the gamma power of the electroencephalogram (EEG) have been suggested. Chronic treatment with the selective serotonin reuptake...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papp, Noémi, Koncz, Szabolcs, Kostyalik, Diána, Kitka, Tamás, Petschner, Péter, Vas, Szilvia, Bagdy, György
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000428/ https://www.ncbi.nlm.nih.gov/pubmed/32063851 http://dx.doi.org/10.3389/fphar.2019.01636

Ejemplares similares

Analysis of sleep EEG during rebound sleep after three days REM deprivation
por: Kostyalik, Diána, et al.
Publicado: (2009)

Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Markov chains
por: Kostyalik, Diána, et al.
Publicado: (2014)

EEG and Sleep Effects of Tramadol Suggest Potential Antidepressant Effects with Different Mechanisms of Action
por: Koncz, Szabolcs, et al.
Publicado: (2021)

Additive effect of 5-HT2C and CB1 receptor blockade on the regulation of sleep–wake cycle
por: Bogáthy, Emese, et al.
Publicado: (2019)

(S)-Ketamine but Not (R)-Ketamine Shows Acute Effects on Depression-Like Behavior and Sleep-Wake Architecture in Rats
por: Koncz, Szabolcs, et al.
Publicado: (2023)

A single neurotoxic dose of MDMA decreases BDNF expression in the frontoparietal cortex but not in the hippocampus
por: Vas, Szilvia, et al.
Publicado: (2009)

AM-251, A Cannabinoid Antagonist, Modifies the Dynamics of Sleep–Wake Cycles in Rats
por: Bogáthy, Emese, et al.
Publicado: (2019)

Serotonin regulation of intermittent and continuous alcohol drinking in male and female C57BL/6J mice with systemic SB242084 and buspirone
por: Ko, Yeasong E, et al.
Publicado: (2023)

Interleukin-6 promoter polymorphism interacts with pain and life stress influencing depression phenotypes
por: Kovacs, David, et al.
Publicado: (2016)

Effects of Different Stressors Are Modulated by Different Neurobiological Systems: The Role of GABA-A Versus CB1 Receptor Gene Variants in Anxiety and Depression
por: Gonda, Xenia, et al.
Publicado: (2019)

Nesfatin-1/NUCB2 as a Potential New Element of Sleep Regulation in Rats
por: Vas, Szilvia, et al.
Publicado: (2013)

Downregulation of the Vitamin D Receptor Regulated Gene Set in the Hippocampus After MDMA Treatment
por: Petschner, Peter, et al.
Publicado: (2018)

Smooth termination of intruder bands in $^{109}$Sb and $^{51}$Sb
por: Schnare, H, et al.
Publicado: (1996)

Antidepressant treatment response is modulated by genetic and environmental factors and their interactions
por: Kovacs, Dávid, et al.
Publicado: (2014)

The UKB envirome of depression: from interactions to synergistic effects
por: Hullam, Gabor, et al.
Publicado: (2019)

Selective serotonin reuptake inhibitor escitalopram inhibits 5-HT(3) receptor currents in NCB-20 cells
por: Park, Yong Soo, et al.
Publicado: (2019)

Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti rats
por: Petschner, Peter, et al.
Publicado: (2013)

Retraction Note to: Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti rats
por: Petschner, Peter, et al.
Publicado: (2016)

Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark Agouti rats
por: Petschner, Peter, et al.
Publicado: (2018)

The rise and fall of CB(1) receptor antagonists: possible future perspectives
por: Bagdy, György
Publicado: (2011)

Band-inverted gaps in InAs/GaSb and GaSb/InAs core-shell nanowires
por: Luo, Ning, et al.
Publicado: (2016)

Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor
por: Okada, Motohiro, et al.
Publicado: (2021)

Escitalopram induced mania
por: Parker, Shubangi, et al.
Publicado: (2007)

Escitalopram in patients with psoriasis
por: Artemieva, M., et al.
Publicado: (2021)

Escitalopram Induced Angioedema
por: Conde, Samantha L, et al.
Publicado: (2022)

Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes
por: Tamási, Viola, et al.
Publicado: (2014)

The 5-HT(2C) receptor agonist, lorcaserin, and the 5-HT(6) receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour
por: Higgs, Suzanne, et al.
Publicado: (2015)

A replication study separates polymorphisms behind migraine with and without depression
por: Petschner, Peter, et al.
Publicado: (2021)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Wake-Promoting and EEG Spectral Effects of Modafinil After Acute or Chronic Administration in the R6/2 Mouse Model of Huntington’s Disease
por: Vas, Szilvia, et al.
Publicado: (2020)

Inflammation and Blood-Brain Barrier in Depression: Interaction of CLDN5 and IL6 Gene Variants in Stress-Induced Depression
por: Gal, Zsofia, et al.
Publicado: (2022)

Interaction between escitalopram and risperidone
por: Rao, Pradeep, et al.
Publicado: (2005)

Severe hyponatremia associated with escitalopram
por: Rawal, Gautam, et al.
Publicado: (2017)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

Rise of escitalopram and the fall of citalopram
por: Cavanah, Luke R., et al.
Publicado: (2023)

Effects of the Selective 5-HT7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-like Deficits in Rats
por: Nikiforuk, Agnieszka, et al.
Publicado: (2013)

The 5-HT(7) receptor antagonist SB 269970 ameliorates corticosterone-induced alterations in 5-HT(7) receptor-mediated modulation of GABAergic transmission in the rat dorsal raphe nucleus
por: Sowa, Joanna, et al.
Publicado: (2018)

Prolactin-Releasing Peptide Contributes to Stress-Related Mood Disorders and Inhibits Sleep/Mood Regulatory Melanin-Concentrating Hormone Neurons in Rats
por: Vas, Szilvia, et al.
Publicado: (2023)

Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats
por: Leiser, S C, et al.
Publicado: (2014)

High Positive MR and Energy Band Structure of RuSb(2+)
por: Zhang, Liang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_494gf218e5e4a5gulb3046qkj0